UBS Group’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

UBS Group’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5	Closed	–	–	11579
2021 Q4	$0	Hold	5	–	–	﹤0.01%	11231
2021 Q3	$0	Hold	5	–	–	﹤0.01%	10602
2021 Q2	$0	Buy	+5	New	+$14	﹤0.01%	10207
2021 Q1	–	Sell	-610	Closed	-$1K	–	9783
2020 Q4	$1K	Buy	+610	New	+$1.21K	﹤0.01%	8308
2020 Q2	–	Sell	-500	Closed	–	–	8560
2020 Q1	$0	Hold	500	–	–	﹤0.01%	8626
2019 Q4	$1K	Buy	+500	New	+$705	﹤0.01%	8026

UBS Group's NFH.WS Position: Q1 2022 in Review

UBS Group sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2022, closing a stake of 5 shares.

UBS Group first reported a position in NFH.WS in Q4 2019 and held it in 6 quarters. The position peaked at $1K in Q4 2020. 0 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2022.

UBS Group reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2022 after selling out during the quarter.
UBS Group sold 5 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2022.
UBS Group first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 6 quarters.
UBS Group's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $1K in Q4 2020.
0 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.